125 related articles for article (PubMed ID: 38336583)
1. Improving quantitative susceptibility mapping for the identification of traumatic brain injury neurodegeneration at the individual level.
Domínguez D JF; Stewart A; Burmester A; Akhlaghi H; O'Brien K; Bollmann S; Caeyenberghs K
Z Med Phys; 2024 Feb; ():. PubMed ID: 38336583
[TBL] [Abstract][Full Text] [Related]
2. QSMxT: Robust masking and artifact reduction for quantitative susceptibility mapping.
Stewart AW; Robinson SD; O'Brien K; Jin J; Widhalm G; Hangel G; Walls A; Goodwin J; Eckstein K; Tourell M; Morgan C; Narayanan A; Barth M; Bollmann S
Magn Reson Med; 2022 Mar; 87(3):1289-1300. PubMed ID: 34687073
[TBL] [Abstract][Full Text] [Related]
3. Toward in vivo histology: a comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2*-imaging at ultra-high magnetic field strength.
Deistung A; Schäfer A; Schweser F; Biedermann U; Turner R; Reichenbach JR
Neuroimage; 2013 Jan; 65():299-314. PubMed ID: 23036448
[TBL] [Abstract][Full Text] [Related]
4. Multi-atlas tool for automated segmentation of brain gray matter nuclei and quantification of their magnetic susceptibility.
Li X; Chen L; Kutten K; Ceritoglu C; Li Y; Kang N; Hsu JT; Qiao Y; Wei H; Liu C; Miller MI; Mori S; Yousem DM; van Zijl PCM; Faria AV
Neuroimage; 2019 May; 191():337-349. PubMed ID: 30738207
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Quantitative MRI susceptibility mapping reveals cortical signatures of changes in iron, calcium and zinc in malformations of cortical development in children with drug-resistant epilepsy.
Lorio S; Sedlacik J; So PW; Parkes HG; Gunny R; Löbel U; Li YF; Ogunbiyi O; Mistry T; Dixon E; Adler S; Cross JH; Baldeweg T; Jacques TS; Shmueli K; Carmichael DW
Neuroimage; 2021 Sep; 238():118102. PubMed ID: 34058334
[TBL] [Abstract][Full Text] [Related]
7. Multi-centre, multi-vendor reproducibility of 7T QSM and R
Rua C; Clarke WT; Driver ID; Mougin O; Morgan AT; Clare S; Francis S; Muir KW; Wise RG; Carpenter TA; Williams GB; Rowe JB; Bowtell R; Rodgers CT
Neuroimage; 2020 Dec; 223():117358. PubMed ID: 32916289
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Brain Venous Structure in Military Traumatic Brain Injury Patients using Susceptibility Weighted Imaging and Quantitative Susceptibility Mapping.
Liu W; Yeh PH; Nathan DE; Song C; Wu H; Bonavia GH; Ollinger J; Riedy G
J Neurotrauma; 2019 Jul; 36(14):2213-2221. PubMed ID: 30760096
[TBL] [Abstract][Full Text] [Related]
9. Joint 2D and 3D phase processing for quantitative susceptibility mapping: application to 2D echo-planar imaging.
Wei H; Zhang Y; Gibbs E; Chen NK; Wang N; Liu C
NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 26887812
[TBL] [Abstract][Full Text] [Related]
10. Visualization of thalamic calcium influx with quantitative susceptibility mapping as a potential imaging biomarker for repeated mild traumatic brain injury.
Schweser F; Kyyriäinen J; Preda M; Pitkänen A; Toffolo K; Poulsen A; Donahue K; Levy B; Poulsen D
Neuroimage; 2019 Oct; 200():250-258. PubMed ID: 31201986
[TBL] [Abstract][Full Text] [Related]
11. Towards in vivo ground truth susceptibility for single-orientation deep learning QSM: A multi-orientation gradient-echo MRI dataset.
Shi Y; Feng R; Li Z; Zhuang J; Zhang Y; Wei H
Neuroimage; 2022 Nov; 261():119522. PubMed ID: 35905811
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous voxel-based magnetic susceptibility and morphometry analysis using magnetization-prepared spoiled turbo multiple gradient echo.
Kan H; Uchida Y; Arai N; Ueki Y; Aoki T; Kasai H; Kunitomo H; Hirose Y; Matsukawa N; Shibamoto Y
NMR Biomed; 2020 May; 33(5):e4272. PubMed ID: 32043682
[TBL] [Abstract][Full Text] [Related]
13. Nuclei-specific deposits of iron and calcium in the rat thalamus after status epilepticus revealed with quantitative susceptibility mapping (QSM).
Aggarwal M; Li X; Gröhn O; Sierra A
J Magn Reson Imaging; 2018 Feb; 47(2):554-564. PubMed ID: 28580758
[TBL] [Abstract][Full Text] [Related]
14. Emerging Applications for Quantitative Susceptibility Mapping in the Detection of Traumatic Brain Injury Pathology.
Gozt A; Hellewell S; Ward PGD; Bynevelt M; Fitzgerald M
Neuroscience; 2021 Jul; 467():218-236. PubMed ID: 34087394
[TBL] [Abstract][Full Text] [Related]
15. STrategically Acquired Gradient Echo (STAGE) imaging, part I: Creating enhanced T1 contrast and standardized susceptibility weighted imaging and quantitative susceptibility mapping.
Chen Y; Liu S; Wang Y; Kang Y; Haacke EM
Magn Reson Imaging; 2018 Feb; 46():130-139. PubMed ID: 29056394
[TBL] [Abstract][Full Text] [Related]
16. Learning-based single-step quantitative susceptibility mapping reconstruction without brain extraction.
Wei H; Cao S; Zhang Y; Guan X; Yan F; Yeom KW; Liu C
Neuroimage; 2019 Nov; 202():116064. PubMed ID: 31377323
[TBL] [Abstract][Full Text] [Related]
17. Brain iron assessment in patients with First-episode schizophrenia using quantitative susceptibility mapping.
Xu M; Guo Y; Cheng J; Xue K; Yang M; Song X; Feng Y; Cheng J
Neuroimage Clin; 2021; 31():102736. PubMed ID: 34186296
[TBL] [Abstract][Full Text] [Related]
18. Human brain atlas for automated region of interest selection in quantitative susceptibility mapping: application to determine iron content in deep gray matter structures.
Lim IA; Faria AV; Li X; Hsu JT; Airan RD; Mori S; van Zijl PC
Neuroimage; 2013 Nov; 82():449-69. PubMed ID: 23769915
[TBL] [Abstract][Full Text] [Related]
19. On the value of QSM from MPRAGE for segmenting and quantifying iron-rich deep gray matter.
Naji N; Sun H; Wilman AH
Magn Reson Med; 2020 Sep; 84(3):1486-1500. PubMed ID: 32125012
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
